2. Signaling Pathways
  3. GPCR/G Protein
    Neuronal Signaling
  4. Opioid Receptor
  5. Opioid Receptor Control

Opioid Receptor Control

Opioid Receptor Isoform Comparison

Opioid Receptor Controls (6):

Cat. No. Product Name Effect Purity
  • HY-B0505
    Moguisteine
    		Control 99.92%
    Moguisteine (BBR-2173) is a cough suppressant compound.
  • HY-122489A
    (S)-Laudanosine
    		Control 99.95%
    (S)-Laudanosine is an alkaloid that can be found in poppies and is the S-enantiomer of Laudanosine. Laudanosine acts on the central nervous system and cardiovascular system, inhibiting low-affinity GABA receptors with an IC50 value of 10 μM, and can cause seizures, hypotension, and bradycardia. Additionally, Laudanosine exerts analgesic effects by competitively binding to the opioid Mu-1 receptor (Ki = 2.7 μM).
  • HY-P3045
    Bilaid B
    		Control
    Bilaid B (compound 2a) is a tetrapeptide. Bilaid B resembles opioid peptides albeit with a unique, alternating LDLD amino acid configuration. .
  • HY-131930
    AH-8533
    		Control
    AH-8533 is a opioid agent.
  • HY-N13293
    Isopaynantheine
    		Control
    Isopaynantheine (3-Isopaynantheine), an alkaloid, is an opioid. Isopaynantheine has antinociceptive activity in mice.
  • HY-W318577
    4-Hydroxy-1-(2-phenylethyl)piperidine
    		Control
    4-Hydroxy-1-(2-phenylethyl)piperidine is a building block that has been used in the synthesis of ligands of the muscarinic acetylcholine receptor (mAChR) or sigma non-opioid intracellular receptor 1 (σ1 receptor). 4-Hydroxy-1-(2-phenylethyl)piperidine is also a metabolite of the opioids furanyl fentanyl and 4-fluoroisobutyryl fentanyl (FIBF).